瘤衍生的细胞外囊中的癌症特异性RNA修饰促进瘤生长
Yuya Monoe1, Kentaro Jingushi1, Kohei Taniguchi2
1Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Journal of extracellular vesicles
|May 6, 2025
概括
癌细胞释放具有改变RNA修饰的细胞外囊泡 (EVs),如N6-甲基氨酸 (m6A),通过影响免疫细胞来促进瘤生长. 在EV中恢复m6A水平抑制了瘤的进展.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- RNA修改对细胞功能至关重要,它们的失调与癌症等疾病有关.
- 细胞外囊泡 (EVs) 携带各种RNA,但由于RNA数量有限,检测它们中的RNA修饰具有挑战性.
- 研究EVs中的RNA修饰对于了解癌症进展和开发新的诊断或治疗策略至关重要.
研究的目的:
- 开发一种检测EVs中的RNA修饰的方法.
- 调查N6-甲基亚丁素 (m6A) 和tRNA碎片在癌症衍生的EVs中的作用.
- 阐明癌症衍生的EVs通过免疫细胞调节促进瘤进展的机制.
主要方法:
- 使用专有超高性能液体染色学串联质谱学 (UHPLC-MS/MS) 系统检测EV中的RNA修饰.
- 在结肠癌和正常组织的EV中,量化N6-甲基氨酸 (m6A) 水平.
- 进行RNA测序来分析tRNA片段,包括m6A修饰的片段,在癌症衍生的EVs.
- 研究了癌症衍生的EVs对巨细胞因子分泌和瘤细胞增殖的功能影响.
- 评估了操纵EV中的m6A水平和耗尽巨细胞对瘤生长的影响.
主要成果:
- 在EV中成功检测到22种不同的RNA修饰.
- 确定了来自结肠癌组织的EV中的m6A水平显著降低,与癌症复发相关.
- 证明通过敲除Alkbh5基因在EVs中增加m6A水平可以抑制结直肠癌EVs的促进瘤效应.
- 表明癌症衍生的EVs以m6A依赖的方式增强巨细胞的促炎性细胞因子分泌 (TNF-α,IL-6),促进癌症细胞的增殖.
- 在结直肠癌EV中发现了5'-半tRNA片段 (5'-半) -GlyGCC和减少m6A-修饰的5'-半GlyGCC的高水平,这促进了瘤生长,这种效应因巨细胞枯竭而减少.
结论:
- 癌症特异性RNA修饰存在于EV中,在促进瘤进展方面发挥着重要作用.
- 癌症衍生的EV中降低的m6A水平通过调节免疫细胞反应,有助于瘤生长.
- 特定RNA片段的EV介导转移,如5'-半GlyGCC,影响瘤的发展.
- 针对EV中的RNA修饰或它们与免疫细胞的相互作用,为癌症治疗提供了潜在的治疗途径.
更多相关视频
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


